naxagolide has been researched along with lisuride in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diederich, NJ; Goetz, CG | 1 |
| Baumann, G; Chin, L; Lieberman, A | 1 |
| Jones, JH; Lotti, VJ; Martin, GE; Pettibone, DJ; Taylor, DA; Williams, M; Zrada, MM | 1 |
| Czuczwar, SJ; Löscher, W | 1 |
| Alam, AM; Starr, MS | 1 |
1 review(s) available for naxagolide and lisuride
| Article | Year |
|---|---|
Dopaminergic agonists in the treatment of Parkinson's disease.
Topics: Apomorphine; Bromocriptine; Dopamine Agents; Humans; Lactose; Lisuride; Methylcellulose; Oxazines; Parkinson Disease; Pergolide; Receptors, Dopamine | 1992 |
4 other study(ies) available for naxagolide and lisuride
| Article | Year |
|---|---|
MK 458, a selective and potent D2 receptor agonist in advanced Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Dopamine Agents; Female; Humans; Hypromellose Derivatives; Lactose; Levodopa; Lisuride; Methylcellulose; Middle Aged; Nausea; Oxazines; Parkinson Disease; Pergolide; Psychomotor Performance; Receptors, Dopamine | 1988 |
Selectivity of (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO] for dopamine receptors in vitro and in vivo.
Topics: Animals; Apomorphine; Cats; Clonidine; Ergolines; In Vitro Techniques; Lisuride; Male; Muscle Contraction; Mydriatics; Oxazines; Pergolide; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Receptors, Serotonin; Serotonin; Vas Deferens | 1985 |
Studies on the involvement of dopamine D-1 and D-2 receptors in the anticonvulsant effect of dopamine agonists in various rodent models of epilepsy.
Topics: Animals; Anticonvulsants; Apomorphine; Female; Gerbillinae; Kindling, Neurologic; Levodopa; Lisuride; Male; Mice; Oxazines; Rats; Receptors, Dopamine; Stimulation, Chemical | 1986 |
Bimodal effects of dopamine D2 receptor agonists on zero Mg(2+)-induced epileptiform activity in the rat cingulate cortex slice.
Topics: Animals; Benzazepines; Dopamine D2 Receptor Antagonists; Epilepsy; Ergolines; Evoked Potentials; Female; Gyrus Cinguli; In Vitro Techniques; Lisuride; Magnesium; Male; Oxazines; Phenethylamines; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Tetrahydronaphthalenes | 1994 |